Cochrane systematic reviews are widely considered to be the ”gold standard” of research synthesis. Established in 1997, the Cochrane Review Group on HIV/AIDS brings together researchers from around the world in preparing and updating rigorous systematic reviews of HIV/AIDS intervention research. In a field evolving as rapidly as HIV/AIDS research, the best evidence to support prevention and treatment decisions may not always be clear. This is especially true in resource-constrained settings. Cochrane systematic reviews on HIV/AIDS topics assist clinicians, public health practitioners, policy makers and consumers in making evidence-based decisions about HIV/AIDS prevention and treatment, and provide direct translation of cutting-edge research into practice.
Because of our expertise and experience in the rigorous, evidence-based synthesis of HIV/AIDS research, many key national and international health agencies have requested our help in developing guidelines and other important policy statements.
PPHG’s Cochrane HIV/AIDS Group was closely involved in developing new WHO Guidelines, released April 2012, on HIV testing and counseling for couples, including antiretroviral therapy for treatment and prevention of HIV in serodiscordant couples. The group, led by PPHG Director George Rutherford, prepared several comprehensive systematic reviews to gather and synthesize the evidence, and participated in the global consensus meeting and final guidelines preparation.
As the editorial base of the Cochrane Collaboration’s Review Group on HIV/AIDS, we are internationally recognized world leaders in the rigorous, evidence-based synthesis of HIV/AIDS research. Our work has informed the development of guidelines and policy statements for many key agencies, including the Centers for Disease Control and Prevention (CDC), the United Nations Population Fund (UNFPA), the Joint United Nations Programme on HIV/AIDS (UNAIDS), and the World Health Organization (WHO).